Quince Therapeutics, Inc.

Filer record as of 2026-09-14. Source: SEC EDGAR

Business address: 611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO, CA, 94080
Category: Non-accelerated filer<br>Smaller reporting company
Cik: 1662774
Edgar url: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1662774
Entity type: operating
Exchanges: Nasdaq
Fiscal year end: 1231
Former names: Cortexyme, Inc.
Name: Quince Therapeutics, Inc.
Sic: 2836
Sic description: Biological Products, (No Diagnostic Substances)
State of incorporation: CA
Tickers: QNCX

Filings